Current scenario of biomarkers in cervical cancer and oncogenesis by HPV
Cervical cancer (CC) is related to HPV infection and represents the third cause of cancer in women. Annually, more than 500,000 new cases are reported worldwide, with significant death rates. It develops due to genetic and epigenetic alterations that control cell growth and differentiation, and may...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zeppelini Editorial e Comunicacao
2019-09-01
|
| Series: | DST |
| Online Access: | https://bjstd.org/revista/article/view/864 |
| _version_ | 1811176665538101248 |
|---|---|
| author | Luciane Rocha Ernlund Pangracio Danielle Betina de Oliveira Traesel Newton Sérgio de Carvalho Maria da Graça Bicalho |
| author_facet | Luciane Rocha Ernlund Pangracio Danielle Betina de Oliveira Traesel Newton Sérgio de Carvalho Maria da Graça Bicalho |
| author_sort | Luciane Rocha Ernlund Pangracio |
| collection | DOAJ |
| description |
Cervical cancer (CC) is related to HPV infection and represents the third cause of cancer in women. Annually, more than 500,000 new cases are reported worldwide, with significant death rates. It develops due to genetic and epigenetic alterations that control cell growth and differentiation, and may cause death. These alterations induce uncontrolled cell division and invasion of cervical tissue have severe consequences to women’s health(1). CC incidence and mortality drop considerably since the implementation of screening tests and vaccination strategies. Nevertheless, CC continues to have a high incidence, mainly in low-income countries, where these programs do not cover territorial frontiers and there is lack of resources to implement vaccination or screening tests. Oncogenic HPV types reached 25% of cases in Brazil over the last years(2), and there was no modification on HPV types after four years of the vaccination program, according to Tota et al.(3). Usually, screening tests in Brazil cover women from 25 to 64 years old. According to Teixeira et al.(4), rates of CC under the age of 25 tend to increase, and women over 64 achieved roughly 20% of CC on research of Brazilian women from two high-income cities. [...]
|
| first_indexed | 2024-04-10T19:55:23Z |
| format | Article |
| id | doaj.art-da89123d122648f491164d845d7993c1 |
| institution | Directory Open Access Journal |
| issn | 2177-8264 |
| language | English |
| last_indexed | 2024-04-10T19:55:23Z |
| publishDate | 2019-09-01 |
| publisher | Zeppelini Editorial e Comunicacao |
| record_format | Article |
| series | DST |
| spelling | doaj.art-da89123d122648f491164d845d7993c12023-01-28T01:05:54ZengZeppelini Editorial e ComunicacaoDST2177-82642019-09-01314Current scenario of biomarkers in cervical cancer and oncogenesis by HPVLuciane Rocha Ernlund PangracioDanielle Betina de Oliveira TraeselNewton Sérgio de CarvalhoMaria da Graça Bicalho Cervical cancer (CC) is related to HPV infection and represents the third cause of cancer in women. Annually, more than 500,000 new cases are reported worldwide, with significant death rates. It develops due to genetic and epigenetic alterations that control cell growth and differentiation, and may cause death. These alterations induce uncontrolled cell division and invasion of cervical tissue have severe consequences to women’s health(1). CC incidence and mortality drop considerably since the implementation of screening tests and vaccination strategies. Nevertheless, CC continues to have a high incidence, mainly in low-income countries, where these programs do not cover territorial frontiers and there is lack of resources to implement vaccination or screening tests. Oncogenic HPV types reached 25% of cases in Brazil over the last years(2), and there was no modification on HPV types after four years of the vaccination program, according to Tota et al.(3). Usually, screening tests in Brazil cover women from 25 to 64 years old. According to Teixeira et al.(4), rates of CC under the age of 25 tend to increase, and women over 64 achieved roughly 20% of CC on research of Brazilian women from two high-income cities. [...] https://bjstd.org/revista/article/view/864 |
| spellingShingle | Luciane Rocha Ernlund Pangracio Danielle Betina de Oliveira Traesel Newton Sérgio de Carvalho Maria da Graça Bicalho Current scenario of biomarkers in cervical cancer and oncogenesis by HPV DST |
| title | Current scenario of biomarkers in cervical cancer and oncogenesis by HPV |
| title_full | Current scenario of biomarkers in cervical cancer and oncogenesis by HPV |
| title_fullStr | Current scenario of biomarkers in cervical cancer and oncogenesis by HPV |
| title_full_unstemmed | Current scenario of biomarkers in cervical cancer and oncogenesis by HPV |
| title_short | Current scenario of biomarkers in cervical cancer and oncogenesis by HPV |
| title_sort | current scenario of biomarkers in cervical cancer and oncogenesis by hpv |
| url | https://bjstd.org/revista/article/view/864 |
| work_keys_str_mv | AT lucianerochaernlundpangracio currentscenarioofbiomarkersincervicalcancerandoncogenesisbyhpv AT daniellebetinadeoliveiratraesel currentscenarioofbiomarkersincervicalcancerandoncogenesisbyhpv AT newtonsergiodecarvalho currentscenarioofbiomarkersincervicalcancerandoncogenesisbyhpv AT mariadagracabicalho currentscenarioofbiomarkersincervicalcancerandoncogenesisbyhpv |